| Literature DB >> 18443959 |
Hiromi Mukaide1, Yasushi Adachi, Shigeru Taketani, Masayoshi Iwasaki, Naoko Koike-Kiriyama, Akio Shigematsu, Ming Shi, Seiji Yanai, Kazuhiko Yoshioka, Yasuo Kamiyama, Susumu Ikehara.
Abstract
It has been reported, as a result of Western blot analyses, that FKBP51 is expressed in various tissues, but that it is not expressed in the pancreas, lung, colon, stomach, or spleen. In this paper, we show, using Western blot analyses, reverse transcriptase polymerase chain reaction, and immunohistochemical analyses of samples from colon cancer patients, that both normal epithelial cells and adenocarcinoma in the human colon express FKBP51, and that there are no significant differences in the expressions of FKBP51 between them. We also show that FKBP51 suppresses the proliferation of colorectal adenocarcinoma, possibly due to the suppression of functions of the glucocorticoid receptors.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18443959 DOI: 10.1080/07357900701799228
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176